Atomoxetine in abstinent cocaine users: Sex differences

Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were...

Descripción completa

Detalles Bibliográficos
Autores principales: DeVito, Elise E., Herman, Aryeh I., Konkus, Noah S., Zhang, Huiping, Sofuoglu, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Pharmacology, Toxicology and Pharmaceutical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568877/
https://www.ncbi.nlm.nih.gov/pubmed/28861456
http://dx.doi.org/10.1016/j.dib.2017.08.011
_version_ 1783258897593663488
author DeVito, Elise E.
Herman, Aryeh I.
Konkus, Noah S.
Zhang, Huiping
Sofuoglu, Mehmet
author_facet DeVito, Elise E.
Herman, Aryeh I.
Konkus, Noah S.
Zhang, Huiping
Sofuoglu, Mehmet
author_sort DeVito, Elise E.
collection PubMed
description Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were assessed. The primary atomoxetine dose analyses (which do not consider sex as a factor) are reported in full elsewhere (DeVito et al., 2017) [1].
format Online
Article
Text
id pubmed-5568877
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-55688772017-08-31 Atomoxetine in abstinent cocaine users: Sex differences DeVito, Elise E. Herman, Aryeh I. Konkus, Noah S. Zhang, Huiping Sofuoglu, Mehmet Data Brief Pharmacology, Toxicology and Pharmaceutical Science Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were assessed. The primary atomoxetine dose analyses (which do not consider sex as a factor) are reported in full elsewhere (DeVito et al., 2017) [1]. Elsevier 2017-08-10 /pmc/articles/PMC5568877/ /pubmed/28861456 http://dx.doi.org/10.1016/j.dib.2017.08.011 Text en © 2017 Published by Elsevier Inc. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Pharmacology, Toxicology and Pharmaceutical Science
DeVito, Elise E.
Herman, Aryeh I.
Konkus, Noah S.
Zhang, Huiping
Sofuoglu, Mehmet
Atomoxetine in abstinent cocaine users: Sex differences
title Atomoxetine in abstinent cocaine users: Sex differences
title_full Atomoxetine in abstinent cocaine users: Sex differences
title_fullStr Atomoxetine in abstinent cocaine users: Sex differences
title_full_unstemmed Atomoxetine in abstinent cocaine users: Sex differences
title_short Atomoxetine in abstinent cocaine users: Sex differences
title_sort atomoxetine in abstinent cocaine users: sex differences
topic Pharmacology, Toxicology and Pharmaceutical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568877/
https://www.ncbi.nlm.nih.gov/pubmed/28861456
http://dx.doi.org/10.1016/j.dib.2017.08.011
work_keys_str_mv AT devitoelisee atomoxetineinabstinentcocaineuserssexdifferences
AT hermanaryehi atomoxetineinabstinentcocaineuserssexdifferences
AT konkusnoahs atomoxetineinabstinentcocaineuserssexdifferences
AT zhanghuiping atomoxetineinabstinentcocaineuserssexdifferences
AT sofuoglumehmet atomoxetineinabstinentcocaineuserssexdifferences

Ejemplares similares